BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 20306105)

  • 1. Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib.
    Seiz M; Nölte I; Pechlivanis I; Freyschlag CF; Schmieder K; Vajkoczy P; Tuettenberg J
    Neurosurg Rev; 2010 Jul; 33(3):375-81; discussion 381. PubMed ID: 20306105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma.
    Stockhammer F; Misch M; Koch A; Czabanka M; Plotkin M; Blechschmidt C; Tuettenberg J; Vajkoczy P
    J Neurooncol; 2010 Dec; 100(3):407-15. PubMed ID: 20446016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
    Penas-Prado M; Hess KR; Fisch MJ; Lagrone LW; Groves MD; Levin VA; De Groot JF; Puduvalli VK; Colman H; Volas-Redd G; Giglio P; Conrad CA; Salacz ME; Floyd JD; Loghin ME; Hsu SH; Gonzalez J; Chang EL; Woo SY; Mahajan A; Aldape KD; Yung WK; Gilbert MR; ;
    Neuro Oncol; 2015 Feb; 17(2):266-73. PubMed ID: 25239666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant chemoradiotherapy followed by adjuvant temozolomide improves survival in glioblastoma multiforme.
    Abrey LE
    Curr Neurol Neurosci Rep; 2005 May; 5(3):167-8. PubMed ID: 15865881
    [No Abstract]   [Full Text] [Related]  

  • 5. Metronomic chemotherapy with daily low-dose temozolomide and celecoxib in elderly patients with newly diagnosed glioblastoma multiforme: a retrospective analysis.
    Welzel G; Gehweiler J; Brehmer S; Appelt JU; von Deimling A; Seiz-Rosenhagen M; Schmiedek P; Wenz F; Giordano FA
    J Neurooncol; 2015 Sep; 124(2):265-73. PubMed ID: 26045360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.
    Baumann F; Bjeljac M; Kollias SS; Baumert BG; Brandner S; Rousson V; Yonekawa Y; Bernays RL
    J Neurooncol; 2004; 67(1-2):191-200. PubMed ID: 15072467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.
    Brada M; Hoang-Xuan K; Rampling R; Dietrich PY; Dirix LY; Macdonald D; Heimans JJ; Zonnenberg BA; Bravo-Marques JM; Henriksson R; Stupp R; Yue N; Bruner J; Dugan M; Rao S; Zaknoen S
    Ann Oncol; 2001 Feb; 12(2):259-66. PubMed ID: 11300335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal and intramedullary metastases of glioblastoma multiforme in a patient reoperated during adjuvant radiochemotherapy.
    Grah JJ; Katalinic D; Stern-Padovan R; Paladino J; Santek F; Juretic A; Zarkovic K; Plestina S; Supe M
    World J Surg Oncol; 2013 Mar; 11():55. PubMed ID: 23496844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.
    Clarke JL; Iwamoto FM; Sul J; Panageas K; Lassman AB; DeAngelis LM; Hormigo A; Nolan CP; Gavrilovic I; Karimi S; Abrey LE
    J Clin Oncol; 2009 Aug; 27(23):3861-7. PubMed ID: 19506159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.
    Gogas H; Polyzos A; Stavrinidis I; Frangia K; Tsoutsos D; Panagiotou P; Markopoulos C; Papadopoulos O; Pectasides D; Mantzourani M; Middleton M; Vaiopoulos G; Fountzilas G
    Ann Oncol; 2006 Dec; 17(12):1835-41. PubMed ID: 16980601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra central nervous system metastases from cerebral glioblastoma multiforme in elderly patients. Clinico-pathological remarks on our series of seven cases and critical review of the literature.
    Piccirilli M; Brunetto GM; Rocchi G; Giangaspero F; Salvati M
    Tumori; 2008; 94(1):40-51. PubMed ID: 18468334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
    Nieder C; Adam M; Grosu AL
    Rev Recent Clin Trials; 2006 Jan; 1(1):43-51. PubMed ID: 18393779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avoiding glucocorticoid administration in a neurooncological case.
    Rutz HP; Hofer S; Peghini PE; Gutteck-Amsler U; Rentsch K; Meier-Abt PJ; Meier UR; Bernays RL
    Cancer Biol Ther; 2005 Nov; 4(11):1186-9. PubMed ID: 16258258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy for glioblastoma.
    Parney IF; Chang SM
    Cancer J; 2003; 9(3):149-56. PubMed ID: 12952300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
    Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
    Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
    Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
    Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
    Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningeal seeding from glioblastoma multiforme treated with radiotherapy and temozolomide.
    Kuo LT; Tsai SY; Yang CY; Lin LW
    Asian J Surg; 2017 Jan; 40(1):61-65. PubMed ID: 23978432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.
    Beauchesne P; Quillien V; Faure G; Bernier V; Noel G; Quetin P; Gorlia T; Carnin C; Pedeux R
    Int J Cancer; 2016 Mar; 138(6):1538-44. PubMed ID: 26501997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-operative management of primary glioblastoma multiforme in patients over 60 years of age.
    Daróczi B; Szántó E; Tóth J; Barzó P; Bognár L; Bakó G; Szántó J; Mózes P; Hideghéty K
    Ideggyogy Sz; 2013 Nov; 66(11-12):391-8. PubMed ID: 24555238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.